{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:40:19Z","timestamp":1791862819510,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","award":["17K09988"],"award-info":[{"award-number":["17K09988"]}]},{"name":"Japanese Ministry of Health, Labour and Welfare"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate upstream and downstream regulators leading to macrophage activation and subsequent cytokine storm in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-associated interstitial lung disease (ILD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted an integrated miRNA-mRNA association analysis using circulating monocytes from 3 patients with anti-MDA5-associated ILD and 3 healthy controls and identified disease pathways and a regulator effect network by Ingenuity Pathway Analysis (IPA). The expression of relevant genes and proteins was verified using an independent validation cohort, including 6 patients with anti-MDA5-associated ILD, 5 with anti-aminoacyl tRNA synthetase antibody-associated ILD, and 6 healthy controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>IPA identified 26 matched pairs of downregulated miRNA and upregulated mRNAs and revealed that canonical pathways mediated by type I IFN signalling and C-C motif ligand 2 (CCL2) were responsible for the pathogenic process (P &amp;lt; 0.05 for all pathways). The regulatory network model identified IFN-\u03b2; Toll-like receptors 3, 7, and 9; and PU.1 as upstream regulators, while the downstream effect of this network converged at the inhibition of viral infection. mRNA and protein expression analysis using validation cohort showed a trend towards the increased expression of relevant molecules identified by IPA in patients with anti-MDA5-associated ILD compared with those with anti-aminoacyl tRNA synthetase antibody-associated ILD or healthy controls. The expression of all relevant genes in monocytes and serum levels of CCL2 and IFN-\u03b2 declined after treatment in survivors with anti-MDA5-associated ILD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>An antiviral proinflammatory network orchestrated primarily by activated monocytes\/macrophages might be responsible for cytokine storm in anti-MDA5-associated ILD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab371","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T23:32:15Z","timestamp":1619134335000},"page":"806-814","source":"Crossref","is-referenced-by-count":48,"title":["Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease"],"prefix":"10.1093","volume":"61","author":[{"given":"Takahisa","family":"Gono","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-6136","authenticated-orcid":false,"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"2022020819090376900_keab371-B1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.chest.2020.01.033","article-title":"Recognition and management of myositis-associated rapidly progressive interstitial lung disease","volume":"158","author":"Jablonski","year":"2020","journal-title":"Chest"},{"key":"2022020819090376900_keab371-B2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrrheum.2016.120","article-title":"Choosing the right biomarkers to predict ILD in myositis","volume":"12","author":"Gono","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2022020819090376900_keab371-B3","doi-asserted-by":"crossref","first-page":"2001618","DOI":"10.1183\/13993003.01618-2020","article-title":"Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?","volume":"56","author":"Giannini","year":"2020","journal-title":"Eur Respir J"},{"key":"2022020819090376900_keab371-B4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMc1900045","article-title":"Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease","volume":"381","author":"Chen","year":"2019","journal-title":"N Engl J Med"},{"key":"2022020819090376900_keab371-B5","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa906","article-title":"Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive myositis","author":"Zhang","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2022020819090376900_keab371-B6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr.22728","article-title":"Anti-melanoma differentiation-associated gene 5 is associated with rapidly progressive lung disease and poor survival in US patients with amyopathic and myopathic dermatomyositis","volume":"68","author":"Moghadam-Kia","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022020819090376900_keab371-B7","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","article-title":"Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients","volume":"57","author":"Sato","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2022020819090376900_keab371-B8","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","article-title":"Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease","volume":"53","author":"Gono","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2022020819090376900_keab371-B9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/14397595.2014.900843","article-title":"Serum interferon-\u03b1 is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis","volume":"25","author":"Horai","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2022020819090376900_keab371-B10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/joim.13154","article-title":"IL-15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis\/dermatomyositis","volume":"289","author":"Shimizu","year":"2021","journal-title":"J Intern Med"},{"key":"2022020819090376900_keab371-B11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"2022020819090376900_keab371-B12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.41566","article-title":"Risk prediction modeling based on a combination of initial serum biomarkers in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"73","author":"Gono","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2022020819090376900_keab371-B13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2022020819090376900_keab371-B14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/cei.13404","article-title":"A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis","volume":"199","author":"Peng","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"2022020819090376900_keab371-B15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3899\/jrheum.180825","article-title":"Clinical significance of serum chitotriosidase level in anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease","volume":"46","author":"Fujisawa","year":"2019","journal-title":"J Rheumatol"},{"key":"2022020819090376900_keab371-B16","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/kez185","article-title":"Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD","volume":"58","author":"Horiike","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2022020819090376900_keab371-B17","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1093\/rheumatology\/keaa034","article-title":"Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis","volume":"59","author":"Zuo","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2022020819090376900_keab371-B18","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022020819090376900_keab371-B19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"key":"2022020819090376900_keab371-B20","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022020819090376900_keab371-B21","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/art.1780281207","article-title":"Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts","volume":"28","author":"Forman","year":"1985","journal-title":"Arthritis Rheum"},{"key":"2022020819090376900_keab371-B22","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1038\/s41598-018-25310-1","article-title":"Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia","volume":"8","author":"Kawai","year":"2018","journal-title":"Sci Rep"},{"key":"2022020819090376900_keab371-B23","doi-asserted-by":"crossref","first-page":"e0199734","DOI":"10.1371\/journal.pone.0199734","article-title":"A whole-genome transcriptome analysis of articular chondrocytes in secondary osteoarthritis of the hip","volume":"13","author":"Aki","year":"2018","journal-title":"PLoS One"},{"key":"2022020819090376900_keab371-B24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"2022020819090376900_keab371-B25","doi-asserted-by":"crossref","first-page":"e0126439","DOI":"10.1371\/journal.pone.0126439","article-title":"Next-generation sequencing analysis reveals differential expression profiles of miRNA-mRNA target pairs in KSHV-infected cells","volume":"10","author":"Viollet","year":"2015","journal-title":"PLoS One"},{"key":"2022020819090376900_keab371-B26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fonc.2019.00910","article-title":"Integrated tanscriptome and pathway analyses revealed multiple activated pathways in breast cancer","volume":"9","author":"Vishnubalaji","year":"2019","journal-title":"Front Oncol"},{"key":"2022020819090376900_keab371-B27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/rheumatology\/key386","article-title":"The relationship between type I IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients","volume":"58","author":"Ono","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2022020819090376900_keab371-B28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"2022020819090376900_keab371-B29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1073\/pnas.022637199","article-title":"MDA-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties","volume":"99","author":"Kang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022020819090376900_keab371-B30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.it.2015.01.004","article-title":"Interferons and viruses: an evolutionary arms race of molecular interactions","volume":"36","author":"Hoffmann","year":"2015","journal-title":"Trends Immunol"},{"key":"2022020819090376900_keab371-B31","doi-asserted-by":"crossref","first-page":"e000336","DOI":"10.1136\/lupus-2019-000336","article-title":"Type I interferons in host defense and inflammatory diseases","volume":"6","author":"Crow","year":"2019","journal-title":"Lupus Sci Med"},{"key":"2022020819090376900_keab371-B32","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.4049\/jimmunol.2000258","article-title":"Alternative activation of macrophages is accompanied by chromatin remodeling associated with lineage-dependent DNA shape features flanking PU.1 motifs","volume":"205","author":"Tang","year":"2020","journal-title":"J Immunol"},{"key":"2022020819090376900_keab371-B33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/imcb.12405","article-title":"Clusterin regulates macrophage expansion, polarization and phagocytic activity in response to inflammation in the kidneys","volume":"99","author":"Weng","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"2022020819090376900_keab371-B34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0000000000000855","article-title":"Where are we moving in the classification of idiopathic inflammatory myopathies?","volume":"33","author":"Tanboon","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"2022020819090376900_keab371-B35","doi-asserted-by":"crossref","first-page":"e001202","DOI":"10.1136\/rmdopen-2020-001202","article-title":"Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease","volume":"6","author":"Nishina","year":"2020","journal-title":"RMD Open"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab371\/38501036\/keab371.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/2\/806\/42368780\/keab371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/2\/806\/42368780\/keab371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T19:11:06Z","timestamp":1644347466000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/2\/806\/6247817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,23]]},"published-print":{"date-parts":[[2022,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab371","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,4,23]]}}}